The relation between different dimensions of alcohol consumption and burden of disease: an overview (original) (raw)

Abstract

AIMS-As part of a larger study to estimate the global burden of disease and injury attributable to alcohol:

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (280)

  1. Rehm J, Room R, Graham K, Monteiro M, Gmel G, Sempos C. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease -an overview. Addiction. 2003; 98:1209-28. [PubMed: 12930209]
  2. Murray CJ, Lopez AD, Black R, Mathers CD, Shibuya K, Ezzati M, et al. Global burden of disease 2005: call for collaborators. Lancet. 2007; 370:109-10. [PubMed: 17630021]
  3. Bruun, K.; Edwards, G.; Lumio, M.; Majeka, K.; Pan, L.; Popham, RE., et al. Alcohol control policies in public health perspective. Helsinki, Finland: Finnish Foundation for Alcohol Studies; 1975.
  4. English, D.; Holman, C.; Milne, E.; Winter, M.; Hulse, G.; Codde, G., et al. The quantification of drug caused morbidity and mortality in Australia 1995. Canberra, Australia: Commonwealth Department of Human Services and Health; 1995.
  5. WHO. International classification of diseases and related health problems, 10th revision (version for 2007). Geneva, Switzerland: WHO; 2007.
  6. Rothman, KJ.; Greenland, S.; Lash, TL. Modern epidemiology.
  7. PA, USA: Lippincott Williams & Wilkins; 2008.
  8. Parascandola M, Weed DL. Causation in epidemiology. J Epidemiol Community Health. 2001; 55:905-12. [PubMed: 11707485]
  9. Walter SD. Prevention of multifactorial disease. Am J Epidemiol. 1980; 112:409-16. [PubMed: 7424889]
  10. Rehm, J.; Room, R.; Monteiro, M.; Gmel, G.; Graham, K.; Rehn, N., et al. Alcohol Use. In: Ezzati, M.; Lopez, AD.; Rodgers, A.; Murray, CJL., editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Vol. 1. Geneva: WHO; 2004. p. 959-1109.
  11. Rehm J, Rehn N, Room R, Monteiro M, Gmel G, Jernigan D, et al. The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res. 2003; 9:147-56. [PubMed: 12970583]
  12. Lachenmeier DW, Rehm J. Unrecorded alcohol: a threat to public health? Addiction. 2009; 104:875-7. [PubMed: 19466914]
  13. Lachenmeier DW, Rehm J, Gmel G. Surrogate alcohol: what do we know and where do we go? Alcohol Clin Exp Res. 2007; 31:1613-24. [PubMed: 17681034]
  14. Ezzati M, Lopez AD, Rodgers AD, Vander Horn S, Murray CJL. Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360:1347-60. [PubMed: 12423980]
  15. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001; 55:508-14. [PubMed: 11413183]
  16. Hill A. The environment and disease: association or causation? Proc R Soc Med. 1965; 58:295- 300. [PubMed: 14283879]
  17. Single, E.; Robson, L.; Xie, X.; Rehm, J.; Moore, R.; Choi, B., et al. The costs of substance abuse in Canada. Ottawa: Canadian Centre on Substance Abuse; 1996.
  18. Single E, Robson L, Rehm J, Xie X. Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Am J Public Health. 1999; 89:385-90. [PubMed: 10076491]
  19. Sjögren H, Eriksson A, Brostrom G, Ahlm K. Quantification of alcohol-related mortality in Sweden. Alcohol Alcohol. 2000; 35:601-11. [PubMed: 11093968]
  20. Gutjahr E, Gmel G, Rehm J. The relation between average alcohol consumption and disease: an overview. Eur Addict Res. 2001; 7:117-27. [PubMed: 11509842]
  21. Ridolfo, B.; Stevenson, C. The quantification of drug-caused mortality and morbidity in Australia 1998. Canberra: Australian Institute of Health and Welfare; 2001.
  22. Gmel G, Rehm J. Harmful alcohol use. Alcohol Res Health. 2003; 27:52-62. [PubMed: 15301400]
  23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21:1539-58. [PubMed: 12111919]
  24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088-101. [PubMed: 7786990]
  25. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-34. [PubMed: 9310563]
  26. Duval SJ, Tweedie RL. Trim and fill: A simple funnel plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56:276-84.
  27. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954; 10:101-29.
  28. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modeling. Applied Statistics. 1994; 43:429-67.
  29. Rehm J, Patra J, Popova S. Alcohol-attributable mortality and potential years of life lost in Canada 2001: Implications for prevention and policy. Addiction. 2006; 101:373-84. [PubMed: 16499510]
  30. Zaridze D, Maximovitch D, Lazarev A, Igitov V, Boroda A, Boreham J, et al. Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol. 2009; 38:143-53. [PubMed: 18775875]
  31. Rehm J. Commentary: alcohol poisoning in Russia: implications for monitoring and comparative risk factor assessment. Int J Epidemiol. 2009; 38:154-5. [PubMed: 18824468]
  32. Gmel G, Kuntsche E, Rehm J. Risky single occasion drinking: a binge is not a binge is not a binge. Addiction. In press.
  33. Parry CDH, Rehm JR, Poznyak V, Room R. Alcohol and infectious diseases: are there causal linkages? Addiction. 2009; 104:331-2. [PubMed: 19207335]
  34. Rush, B. An inquiry into the effects of ardent spirits upon the human body and mind: With an account of the means of preventing, and of the remedies for curing them. 8. Exeter, N.H: Richardson; 1785. Reprint
  35. Lönnroth K, Williams B, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis -a systematic review. BMC Public Health. 2008; 8:289. [PubMed: 18702821]
  36. Rieder, HL. Epidemiologic basis of tuberculosis control. Paris: International Union Against Tuberculosis and Lung Disease; 1999.
  37. Szabo G. Alcohol's contribution to compromised immunity. Alcohol Health Res World. 1997; 21:30-41. [PubMed: 15706761]
  38. Friedman H, Pros S, Klein TW. Addictive drugs and their relationships with infectious diseases. FEMS. 2006; 47:330-42.
  39. Szabo G, Mandrekar P. A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res. 2009; 33:220-32. [PubMed: 19053973]
  40. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry CD, Lönnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. In press.
  41. Jakubowiak WM, Bogorodskaya EM, Borisov ES, Danilova DI, Kourbatova EK. Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis. 2007; 11:46-53. [PubMed: 17217129]
  42. Braithwaite RS, McGinnis KA, Conigliaro J, Maisto S, Crystal S, Day N, et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res. 2005; 29:1190-7. [PubMed: 16046874]
  43. Neuman MG, Monteiro M, Rehm J. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Substance Use Misuse. 2006; 41:1395-463. [PubMed: 17002989]
  44. Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies. Sex Transm Dis. 2007; 34:856-63. [PubMed: 18049422]
  45. Baliunas, D.; Rehm, J.; Irving, H. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Toronto, Canada: Centre for Addiction and Mental Health; 2008. Report to be published in International Journal of Public Health 45. Shuper PA, Joharchi N, Irving H, Rehm J. Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis. AIDS Behav. 2009 Epub ahead of print July 18.
  46. Rehm, J.; Shuper, PA.; Neuman, M.; Kanteres, F.; Baliunas, D.; Joharchi, N. Causal considerations on alcohol and HIV/AIDS -a systematic review. Toronto, ON: CAMH; 2009.
  47. Halpern-Felsher BL, Millstein SG, Ellen JM. Relationship of alcohol use and risky sexual behavior: a review and analysis of findings. J Adolesc Health. 1996; 19:331-6. [PubMed: 8934293]
  48. Kalichman SC, Simbayi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual risks for HIV/ AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci. 2007; 8:141-51. [PubMed: 17265194]
  49. Leigh BC, Stall R. Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention. Am Psychol. 1993; 48:1035-45. [PubMed: 8256876]
  50. Leigh BC. Alcohol and condom use: a meta-analysis of event-level studies. Sex Transm Dis. 2002; 29:476-82. [PubMed: 12172533]
  51. Weinhardt L, Carey M. Does alcohol lead to sexual risk behavior? Findings from event-level research. Annu Rev Sex Res. 2000; 11:125-57. [PubMed: 11351830]
  52. Woolf SE, Maisto SA. Alcohol use and risk of HIV infection among men who have sex with men. AIDS Behav. 2009; 13:757-82. [PubMed: 18236149]
  53. Kalichman SC, Rompa D. Sexual sensation seeking and sexual compulsivity scales reliability, validity, and predicting HIV risk behavior. J Pers Assess. 1995; 65:586-601. [PubMed: 8609589]
  54. Kalichman SC, Heckman T, Kelly JA. Sensation seeking, substance use, and HIV-AIDS risk behavior: directional relationships among gay men. Arch Sex Behav. 1996; 25:141-54. [PubMed: 8740520]
  55. Zuckerman, M. Biological expression and biological bases of sensation seeking. New York: Cambridge University Press; 1994.
  56. Golding M, Perkins DO. Personality disorder in HIV infection. International Review of Psychiatry. 1996; 8:253-8.
  57. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009 epub ahead of print Aug 7.
  58. Rehm, J.; Anderson, P.; Kanteres, F.; Parry, CD.; Samokhvalov, AV.; Patra, J. Alcohol, social development and infectious disease. Toronto, ON: Centre for Addiction and Mental Health; 2009.
  59. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007; 8:292-3. [PubMed: 17431955]
  60. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol. 2006; 7:149-56. [PubMed: 16455479]
  61. Seitz HK, Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health. 2007; 30:38-47. [PubMed: 17718399]
  62. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nature Reviews Cancer. 2007; 7:599-612.
  63. Lachenmeier DW, Sohnius EM. The role of acetaldehyde outside ethanol metabolism in the carcinogenicity of alcoholic beverages: evidence from a large chemical survey. Food Chem Toxicol. 2008; 46:2903-11. [PubMed: 18577414]
  64. Lachenmeier DW, Kanteres F, Rehm J. Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism. Addiction. 2009; 104:533-50. [PubMed: 19335652]
  65. Salaspuro M. Acetaldehyde: a cumulative carcinogen in humans. Addiction. 2009; 104:551-3. [PubMed: 19335653]
  66. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009; 373:2223-33. [PubMed: 19560604]
  67. Cho E, Smith-Warner S, Ritz J, van den Brandt P, Colditz G, Folsom A. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med. 2004; 140:603-13. [PubMed: 15096331]
  68. Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004; 38:613-9. [PubMed: 15066364]
  69. Moskal A, Norat T, Ferrari P, Riboli E. Alcohol intake and colorectal cancer risk: a doseresponse meta-analysis of published cohort studies. Int J Cancer. 2007; 120:664-71. [PubMed: 17096321]
  70. Singletary K, Gapstur S. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001; 286:2143-51. [PubMed: 11694156]
  71. Hamajima N, Hirose K, Tajima K, Rohan T, Calle E, Heath C, et al. Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer. 2002; 87:1234-45. [PubMed: 12439712]
  72. Key J, Hodgson S, Omar RZ, Jensen TK, Thomson SG, Boobis AR, et al. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control. 2006; 17:759-70. [PubMed: 16783604]
  73. Singletary SE. Rating the risk factors for breast cancer. Annals of Surgery. 2003; 237:474-82. [PubMed: 12677142]
  74. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: re-analysis of nine prospective studies. J Natl Cancer Inst. 2002; 94:606-16. [PubMed: 11959894]
  75. Yu H, Berkel H. Do insulin-like growth factors mediate the effect of alcohol on breast cancer risk? Medical Hypotheses. 1999; 52:491-6. [PubMed: 10459827]
  76. Fujimoto WY. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med. 2000; 108:9S-14S. [PubMed: 10764845]
  77. Hendriks HFJ. Moderate alcohol consumption and insulin sensitivity: observations and possible mechanisms. Ann Epidemiol. 2007; 17:S40-S42.
  78. Mayer EJ, Newman B, Quesenberry CP Jr, Friedman GD, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholestrol and triglycerides. Circulation. 1993; 88:2190-7. [PubMed: 8222114]
  79. Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996; 313:1040-4. [PubMed: 8898593]
  80. Lazarus R, Sparrow D, Weiss ST. Alcohol intake and insulin levels. The Normative Aging Study. Am J Epidemiol. 1997; 145:909-16. [PubMed: 9149662]
  81. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002; 287:2559-62. [PubMed: 12020337]
  82. Sierksma A, Patel H, Ouchi N, Kihara S, Funahashi T, Heine RJ, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care. 2004; 27:184-9. [PubMed: 14693987]
  83. Sarkola T, Iles MR, Kohlenberg-Mueller K, Eriksson CJ. Ethanol, acetaldehyde, acetate, and lactate levels after alcohol intake in white men and women: effect of 4-methylpyrazole. Alcohol Clin Exp Res. 2002; 26:239-45. [PubMed: 11964564]
  84. Rimm E, Williams P, Fosher K, Criqui M, Stampfer M. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 19:1523-8. [PubMed: 10591709]
  85. Wannamethee SG, Shaper AG. Alcohol, body weight, and weight gain in middle-aged men. Am J Clin Nutr. 2003; 77:1312-7. [PubMed: 12716687]
  86. Wannamethee SG, Camargo CA jr, Manson JE, Willett WC, Rimm EB. Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Arch Intern Med. 2003; 163:1329-36. [PubMed: 12796069]
  87. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001; 357:763-7. [PubMed: 11253971]
  88. Sierksma A, van der Gaag MS, Kluft C, Hendriks HF. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels: a randomized, diet-controlled intervention study. Eur J Clin Nutr. 2002; 56:1130-6. [PubMed: 12428180]
  89. Hillbom M, Pieninkeronen I, Leone M. Seizures in alcohol-dependent patients. CNS Drugs. 2003; 17:1013-30. [PubMed: 14594442]
  90. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia. 2005; 46:470-2. [PubMed: 15816939]
  91. Ogunniyi A, Osuntokun BO, Bademosi O, Adeuja AOG, Schoenberg BS. Risk factors for epilepsy: case-control study in Nigerians. Epilepsia. 1987; 28:280-5. [PubMed: 3582292]
  92. Ng SKC, Hauser AW, Brust JCM, Susser M. Alcohol consumption and withdrawal in new-onset seizures. N Engl J Med. 1988; 319:666-73. [PubMed: 3412384]
  93. Leone M, Bottacchi E, Gionco M, Nardozza V, Sironi L. Alcohol and epileptic seizures: a case control study. Alcologia. 1994; 6:215-9.
  94. Leone M, Bottachi E, Beghi E, Morgando E, Mutani R, Amedeo G, et al. Alcohol use is a risk factor for a first generalized tonic-clonic seizure. Neurology. 1997; 48:614-20. [PubMed: 9065535]
  95. Leone M, Bottacchi E, Beghi E, Morgando E, Mutani R, Cremo R, et al. Risk factors for a first generalized tonic-clonic seizure in adult life. Neurol Sci. 2002; 23:99-106. [PubMed: 12391493]
  96. Zeng J, Zhen H, Mao-Sheng H, Mei-Hua J. A case-control study on the risk factors and other socio-psychological factors of epilepsy. Chin J Epidemiol. 2003; 24:116-8.
  97. Samokhvalov AV, Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures and epilepsy: a systematic review and meta-analysis. Epilepsia. In press.
  98. Ballenger JC, Post RM. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry. 1978; 133:1-14. [PubMed: 352467]
  99. Dam AM, Fuglsang-Frederikse A, Svarre-Olsen U, Dam M. Late-onset epilepsy: etiologies, types of seizure, and value of clinical investigation, EEG, and computerized tomography scan. Epilepsia. 1985; 26:227-31. [PubMed: 4006882]
  100. Freedland ES, McMicken DB. Alcohol-related seizures, part I: pathophysiology, differencial diagnosis and evaluation. J Emerg Med. 1993; 11:463-73. [PubMed: 8228111]
  101. Rathlev NK, Ulrich AS, Delanty N, D'Onofrio D, D'Onofrio G. Alcohol-related seizures. J Emerg Med. 2006; 31:157-63. [PubMed: 17044577]
  102. Barclay GA, Barvour J, Stewart S, Day CP, Gilvarry E. Adverse physical effects of alcohol misuse. Advances in Psychiatric Treatment. 2008; 14:139-51.
  103. Beilin LJ, Puddey IB. Alcohol and hypertension. Clin Exp Hypertens A. 1992; 14:119-38. [PubMed: 1541032]
  104. Klatsky AL. Alcohol, cardiovascular diseases and diabetes mellitus. Pharmacological Research. 2007; 55:237-472. [PubMed: 17363263]
  105. Randin D, Vollenweider P, Tappy L, Jequier E, Nicod P, Scherrer U. Suppression of alcohol- induced hypertension by dexamethasone. N Engl J Med. 1995; 332:1733-7. [PubMed: 7760888]
  106. el-Mas MM, Abdel-Rahman AA. Direct evidence for selective involvement of aortic baroreceptors in ethanol-induced impairment of baroreflex control of heart rate. J Pharmacol Exp Ther. 1993; 264:1198-205. [PubMed: 8450457]
  107. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine. 2006; 3:e442. [PubMed: 17132052]
  108. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000; 95:1505-23. [PubMed: 11070527]
  109. Criqui M. Alcohol and the heart: Implications of present epidemiologic knowledge. Contemp Drug Probl. 1994; 21:125-42.
  110. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006; 166:2437-45. [PubMed: 17159008]
  111. Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman MA. Prior alcohol consumption and mortality following acute myocardial infarction. JAMA. 2001; 285:1965-70. [PubMed: 11308432]
  112. Tanasescu M, Hu FB, Willett WC, Stampfer MJ, Rimm EB. Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. J Am Coll Cardiol. 2001; 38:1836-42. [PubMed: 11738282]
  113. Koppes LLJ, Dekker JM, Hendricks HF, Bouter LM, Heine RJ. Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia. 2006; 49:648-52. [PubMed: 16463045]
  114. Beulens JW, Rimm EB, Stampfer MJ, Ascherio A, Hendriks HF, Mukamal KJ. Alcohol consumption and risk of coronary heart disease in men with hypertension. Ann Intern Med. 2007; 146:10-9. [PubMed: 17200217]
  115. McKee M, Britton A. The positive relationship between alcohol and heart disease in Eastern Europe: potential physiological mechanisms. J R Soc Med. 1998; 91:402-7. [PubMed: 9816353]
  116. Puddey IB, Rakic V, Dimmitt SB, Beilin LJ. Influence of pattern of drinking on cardiovascular disease and cardiovascular risk factors -A review. Addiction. 1999; 94:649-63. [PubMed: 10563030]
  117. Rehm J, Sempos C, Trevisan M. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease -a review. J Cardiovasc Risk. 2003; 10:15-20. [PubMed: 12569232]
  118. Bagnardi V, Zatonski W, Scotti L, La Vecchia C, Corrao G. Does drinking pattern modify the effect of alcohol on the risk of coronary heart disease? Evidence from a meta-analysis. J Epidemiol Community Health. 2008; 62:615-9. [PubMed: 18559444]
  119. Zakhari S. Alcohol and the cardiovascular system: molecular mechanisms for beneficial and harmful action. Alcohol Health Res World. 1997; 21:21-9. [PubMed: 15706760]
  120. Renaud, SC.; Criqui, MH.; Farchi, G.; Veenstra, J. Alcohol drinking and coronary heart disease. In: Verschuren, PM., editor. Health issues related to alcohol consumption. Washington, DC: International Life Sciences Institute; 1993.
  121. Rankin J. Biological mechanisms at moderate levels of alcohol consumption that may affect coronary heart disease. Contemp Drug Probl. 1994; 21:45-57.
  122. Svärdsudd K. Moderate alcohol consumption and cardiovascular disease: is there evidence for a preventive effect? Alcohol Clin Exp Res. 1998; 22:307S-14S. [PubMed: 9799953]
  123. Mukamal K, Rimm E. Alcohol's effects on the risk for coronary heart disease. Alcohol Res Health. 2001; 25:255-61. [PubMed: 11910702]
  124. Baraona, E.; Lieber, C. Alcohol and lipids. In: Galanter, M., editor. Recent developments in alcoholism, vol 14: The consequences of alcoholism. New York: Plenum Press; 1998. p. 97-134.
  125. Criqui MH, Cowan LD, Tyroler JA, Bangdiwala S, Heiss G, Wallace RB, et al. Lipoprotein medicators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality. Results from the Lipid Research Clinics follow-up study. Am J Epidemiol. 1987; 126:629-37. [PubMed: 3631053]
  126. Criqui M, Ringel B. Does diet or alcohol explain the French paradox? The Lancet. 1994; 344:1719-23.
  127. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001; 344:549-55. [PubMed: 11207350]
  128. Lucas DL, Brown RA, Wassef M, Giles TD. Alcohol and the cardiovascular system -research challenges and opportunities. J Am Coll Cardiol. 2005; 45:1916-24. [PubMed: 15963387]
  129. Collins MA, Neafsey EJ, Mukamal KJ, Gray MO, Parks DA, Das DK, et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res. 2009; 33:206-19. [PubMed: 19032583]
  130. Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group. Ann Intern Med. 1992; 116:881-7. [PubMed: 1580443]
  131. McKenzie, C.; Eisenberg, P. Alcohol, coagulation, and arterial thrombosis. In: Zakhari, S.; Wassef, M., editors. Alcohol and the cardiovascular system. Bethesda, MD: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; 1996. p. 413-439.
  132. Reeder, V.; Aikens, M.; Li, X.; Booyse, F. Alcohol and the fibrinolytic system. In: Zakhari, S.; Wassef, M., editors. Alcohol and the cardiovascular system. Bethesda, MD: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; 1996. p. 391-411.
  133. Fillmore KM, Kerr WC, Stockwell T, Chikritzhs T, Bostrom A. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies. Addict Res Theory. 2006; 14:101- 32.
  134. Shaper A, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U- shaped curve. Lancet. 1988; 2:1267-73. [PubMed: 2904004]
  135. Rimm EB, Moats C. Alcohol and coronary heart disease: drinking patterns and mediators of effect. Ann Epidemiol. 2007; 17:S3-S7.
  136. Klatsky AL, Armstrong MA, Friedman GD. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers, and nondrinkers. Am J Cardiol. 1990; 66:1237-42. [PubMed: 2239729]
  137. Mukamal K, Conigrave K, Mittleman M, Camargo C, Stampfer M, Willett W, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003; 348:109-18. [PubMed: 12519921]
  138. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, Greenfield TK. Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention. Am J Epidemiol. 2008; 168:866-71. [PubMed: 18701442]
  139. Rehm J. On the limitations of observational studies. Addict Res Theory. 2007; 15:20-2.
  140. Poikolainen K. Inebriation and mortality. Int J Epidemiol. 1983; 12:151-5. [PubMed: 6874208]
  141. McElduff P, Dobson A. How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event. BMJ. 1997; 314:1159-64. [PubMed: 9146388]
  142. Trevisan M, Ram M, Hovey K, Russel M, Freudenheim J, Muti P, et al. Alcohol drinking patterns and myocardial infarction. Am J Epidemiol. 2001; 153:S97.
  143. Trevisan M, Schisterman E, Mennotti A, Farchi G, Conti S. Drinking pattern and mortality: The Italian risk factor and life expectancy pooling project. Ann Epidemiol. 2001; 11:312-9. [PubMed: 11399445]
  144. Murray R, Connett J, Tyas S, Bond R, Ekuma O, Silversides C, et al. Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function? Am J Epidemiol. 2002; 155:242-8. [PubMed: 11821249]
  145. Agarwal DP. Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Review. Alcohol Alcohol. 2002; 37:409-15. [PubMed: 12217928]
  146. Balbão CEB, de Paola AAV, Fenelon G. Effects of alcohol on atrial fibrillation. Ther Adv Cardiovasc Dis. 2009; 3:53-63. [PubMed: 19124390]
  147. Lowenstein SR, Gbow P, Cramer J, Olivia PB, Ratner K. The role of alcohol in new-onset atrial fibrillation. Arch Intern Med. 1983; 143:1882-5. [PubMed: 6625772]
  148. Rich EC, Siebold C, Campion B. Alcohol-related acute atrial fibrillation, a case-control study and review of 40 patients. Arch Intern Med. 1985; 145:830-3. [PubMed: 3158290]
  149. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. Europace. 2008; 10:668-73. [PubMed: 18480076]
  150. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA. 1994; 271:840-4. [PubMed: 8114238]
  151. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med. 1995; 98:476-84. [PubMed: 7733127]
  152. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med. 2001; 250:382-9. [PubMed: 11887972]
  153. Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Gronbaek M. Alcohol consumption and risk of atrial fibrillation in men and women -the Copenhagen City Heart Study. Circulation. 2005; 112:1736-42. [PubMed: 16157768]
  154. Planas F, Romero-Menor C, Vasquez-Oliva G, Poblet T, Navarro-López F. Historia natural y factores de riesgo de recurrecnia de la fibrilación auricular primaria (Registro FAP). Revista Española de Cardiología. 2006; 59:1106-12.
  155. Reynolds K, Lewis B, Nolen J, Kinney G, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003; 289:579-88. [PubMed: 12578491]
  156. Sundell L, Salomaa V, Vartiainen E, Poikolainen K, Laatikainen T. Increased stroke risk is related to a binge drinking habit. Stroke. 2008; 39:3179-84. [PubMed: 18832741]
  157. Schütz H, Bödeker RH, Damian M, Krack P, Dorndorf W. Age-related spontaneous intracerebral hematoma in a German community. Stroke. 1990; 21:1412-8. [PubMed: 2219205]
  158. Dulli, DA.; Geraghty, MC. Alcohol and stroke. In: Preedy, VR.; Watson, RR., editors. Comprehensive handbook of alcohol related pathology. Vol. 2. London, UK: Elsevier Academic Press; 2005. p. 627-646.
  159. Rehm J, Taylor B. Alcohol consumption, stroke and public health -an overlooked relation? Addiction. 2006; 101:1679-81. [PubMed: 17156162]
  160. Feigin VL, Rinkel GJE, Lawes CMM, Algra A, Bennett DA, Gijn JV, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005; 36:2773-80. [PubMed: 16282541]
  161. Koivula, IH. Epidemiology of community-acquired pneumonia. In: Marrie, TJ., editor. Community-acquired pneumonia. New York: Kluwer Academic Publishers; 2001. p. 13-27.
  162. Nelson S, Kolls JK. Alcohol, host defence and society. Nature Reviews Immunology. 2002; 2:205-9.
  163. Fernández-Solá J, Junqué A, Estruch R, Monforte R, Torres A, Urbano-Márquez A. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med. 1995; 155:1649-54. [PubMed: 7618989]
  164. Koivula I, Sten M, Mäkelä PH. Risk factors for pneumonia in the elderly. Am J Med. 1994; 96:313-20. [PubMed: 8166149]
  165. Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause- specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet. 2009; 373:2201-14. [PubMed: 19560602]
  166. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med. 1988; 319:1639-50. [PubMed: 3059192]
  167. Bautista, AP. Liver injury during alcohol use and withdrawal. In: Preedy, VR.; Watson, RR., editors. Comprehensive handbook of alcohol related pathology. London, UK: Elsevier Academic Press; 2005. p. 491-500.
  168. Becker, U. Epidemiology and risk factors in alcohol liver disease. In: Preedy, VR.; Watson, RR., editors. Comprehensive handbook of alcohol related pathology. London, UK: Elsevier Academic Press; 2005. p. 467-480.
  169. Neuman M. Cytokines -central factors in alcoholic liver disease. Alcohol Res Health. 2003; 27:307-16. [PubMed: 15540802]
  170. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis -a systematic review and meta-analysis. Drug Alcohol Rev. In press.
  171. Irving HM, Samokhvalov A, Rehm J. Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP. 2009; 10:387-92. [PubMed: 19581740]
  172. Lerch MM, Albrecht E, Ruthenburger M, Mayerle J, Halangk W, Kruger B. Pathophysiology of alcohol-induced pancreatitis. Pancreas. 2003; 27:291-6. [PubMed: 14576489]
  173. Szabo G, Mandrekar P, Oak S, Mayerle J. Effect of ethanol on inflammatory responses: implications for pancreatitis. Pancreatology. 2007; 7:115-23. [PubMed: 17592223]
  174. Vonlaufen A, Wilson JS, Pirola RC, Apte MV. Role of alcohol metabolism in chronic pancreatitis. Alcohol Res Health. 2007; 30:48-54. [PubMed: 17718401]
  175. Tattersall SJ, Apte MV, Wilson JS. A fire inside: current concepts in chronic pancreatitis. J Intern Med. 2008; 38:592-8.
  176. Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005; 141:1537-41. [PubMed: 16365254]
  177. Bowcock AM. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunol Res. 2005; 32:45-56. [PubMed: 16106058]
  178. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med. 1995; 1:442-7. [PubMed: 7585092]
  179. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol. 2002; 46:1-26. [PubMed: 11756941]
  180. Poikolainen K, Reunala T, Karvonen J, Lauharanta J, Karkkainen P. Alcohol intake: a risk factor for psoriasis in young and middle-aged men? BMJ. 1990; 300:780-3. [PubMed: 1969757]
  181. Higgins EM, du Vivier AW. Cutaneous disease and alcohol misuse. Br Med Bull. 1994; 50:85- 98. [PubMed: 7908595]
  182. Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000; 43:1-16. [PubMed: 10863217]
  183. Kostovic K, Lipozencic J. Skin diseases in alcoholics. Acta Dermatovenerol Croat. 2004; 12:181- 90. [PubMed: 15369644]
  184. Behnam SM, Behnam SE, Koo JY. Alcohol as a risk factor for plaque-type psoriasis. Cutis. 2005; 76:181-5. [PubMed: 16268261]
  185. Schäfer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology. 2006; 212:327-37. [PubMed: 16707882]
  186. Dika E, Bardazzi F, Balestri R, Maibach HI. Environmental factors and psoriasis. Curr Probl Dermatol. 2007; 35:118-35. [PubMed: 17641494]
  187. Meyer N, Viraben R, Paul C. Addictions and psoriasis: an example of the dermatologist's implication in preventive medicine? Ann Dermatol Venereol. 2008; 135:S259-S262. [PubMed: 18466794]
  188. Schäfer, T.; Nienhaus, A.; Haupt, G.; Vieluf, D.; Nagel, S.; Berger, J., et al. Befunde der hautuntersuchung und allergologischen diagnostik. In: Behörde für Arbeit, Gesundheit; Soziales der, Freien; Hansestadt, Hamburg, editors. Epidemiologisches Untersuchungsprogramm Bille- Siedlung. Frankfurt am Main: Peter Lang Verlag; 1997. p. 158-194.
  189. Naldi L. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004; 3:121-8. [PubMed: 15180464]
  190. Lindegard B. Diseases associated with psoriasis in a general population of 159 200 middle-aged, urban, native Swedes. Dermatologica. 1986; 172:298-304. [PubMed: 3089849]
  191. Evstaff'ev VV, Levin MM. Dermatologic pathology in chronic alcoholics. Vestn Dermatol Venerol. 1989; 8:72-4. [PubMed: 2530725]
  192. Higgins EM, Peters TJ, du Vivier AW. Smoking, drinking and psoriasis. Br J Dermatol. 1993; 129:749-50. [PubMed: 8286268]
  193. Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriatic patients. Int J Dermatol. 1993; 32:587-91. [PubMed: 8407075]
  194. Kirby B, Richards HL, Manson DL, Fortune DG, Main CJ, Griffiths CEM. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol. 2008; 158:138-40. [PubMed: 17999698]
  195. Vincenti GE, Blunden SM. Psoriasis and alcohol abuse. J R Army Med Corps. 1987; 133:77-8. [PubMed: 3612624]
  196. Bolognia, JL.; Lorizzo, JL.; Rapini, RP. Psoriasis: Dermatology. 2. St. Louis, MO: Mosby Elsevier; 2008.
  197. Gupta MA, Schork NJ, Gupta AK, Ellis CN. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol. 1993; 28:730-2. [PubMed: 8496416]
  198. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004; 140:408-14. [PubMed: 15096368]
  199. Cohen AD, Halevy S. Alcohol intake, immune response, and the skin. Clin Dermatol. 1999; 17:411-2. [PubMed: 10497724]
  200. Higgins EM, du Vivier AW. Alcohol abuse and treatment resistance in skin disease. J Am Acad Dermatol. 1994; 30:1048. [PubMed: 8188882]
  201. Farkas A, Kemeny L, Szell M, Dobozy A, Bata-Csorgo Z. Ethanol and acetone stimulate the proliferation of HaCaT keratinocytes: the possible role of alcohol in exacerbating psoriasis. Arch Dermatol Res. 2003; 295:56-62. [PubMed: 12720008]
  202. Wolf R, Wolf D, Ruocco V. Alcohol intake and psoriasis. Clin Dermatol. 1999; 17:423-30. [PubMed: 10497727]
  203. Albertsen K, Andersen AN, Olsen J, Gronbaek M. Alcohol consumption during pregnancy and the risk of preterm delivery. Am J Epidemiol. 2004; 159:155-61. [PubMed: 14718217]
  204. Kesmodel U, Olsen SF, Secher NJ. Does alcohol increase the risk of preterm delivery? Epidemiol. 2000; 11:512-8.
  205. Larroque B, Kaminski M, Lelong N, Subtil D, Dehaene P. Effects on birth weight of alcohol and caffeine consumption during pregnancy. Am J Epidemiol. 1993; 137:941-50. [PubMed: 8317451]
  206. Lundsberg LS, Bracken MB, Saftlas AF. Low-to-moderate gestational alcohol use and intrauterine growth retardation, low birthweight, and preterm delivery. Ann Epidemiol. 1997; 7:498-508. [PubMed: 9349918]
  207. Parazzini F, Chatenoud L, Surace M, Tozzi L, Salerio B, Bettoni G, et al. Moderate alcohol drinking and risk of preterm birth. Eur J Clin Nutr. 2003; 57:1345-9. [PubMed: 14506499]
  208. McDonald AD, Armstrong BG, Sloan M. Cigarette, alcohol, and coffee consumption and prematurity. Am J Public Health. 1992; 82:87-90. [PubMed: 1536341]
  209. Little RE, Asker RL, Sampson PD, Renwick JH. Fetal growth and moderate drinking in early pregnancy. Am J Epidemiol. 1986; 123:270-8. [PubMed: 3946376]
  210. Cook JL, Randal CL. Ethanol and parturition: a role for prostaglandins. Prostaglandins Leukot Essent Fatty Acids. 1998; 58:135-42. [PubMed: 9578152]
  211. Chaud M, Faletti A, Beron de Estrada M, Gimeno AL, Gimeno MA. Synthesis and release of prostaglandins D2 and E2 by rat uterine tissue throughout the sex cycle. Effects of 17-beta- estradiol and progesterone. Prostaglandins Leukot Essent Fatty Acids. 1994; 51:47-50. [PubMed: 7938098]
  212. Mitchell SN, Smith SK. The effect of progesterone and human interferon alpha-2 on the release of PGF2 alpha and PGE from epithelial cells of human proliferative endometrium. Prostaglandins. 1992; 44:457-70. [PubMed: 1470684]
  213. Pakrasi PL, Cheng HC, Dey SK. Prostaglandins in the uterus: modulation by steroid hormones. Prostaglandins. 1983; 26:991-1009. [PubMed: 6597497]
  214. Ahluwalia B, Smith D, Adeyiga O, Akbasak B, Rajguru S. Ethanol decreases progesterone synthesis in human placental cells: mechanism of ethanol effect. Alcohol. 1992; 9:395-401. [PubMed: 1418664]
  215. Wimalasena J. Ethanol has direct effects on human choriocarcinoma cell steroid hormone secretion. Alcohol Clin Exp Res. 1994; 18:369-74. [PubMed: 8048740]
  216. Challis, J.; Olson, D. Parturition. In: Knobil, E.; Neill, J., editors. The Physiology of Reproduction. New York: Raven Press; 1988. p. 2177-2216.
  217. Abel EL. Consumption of alcohol during pregnancy: a review of effects on growth and development of offspring. Human Biology. 1982; 54:421-53. [PubMed: 6757096]
  218. Mueller J. The banality of "ethnic war". Int Secur. 2000; 25:42-70.
  219. Moskalewicz J. Monopolization of the alcohol arena by the state. Contemp Drug Probl. 1985; 12:117-28.
  220. Gourevitch, P. We wish to inform you that tomorrow we will be killed with our families. New York: Farrar, Straus, & Giroux; 1998.
  221. Buford, B. Among the thugs. London & New York: Secker & Warburg and W.W.Norton; 1991.
  222. Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction. 1999; 94:1551-73. [PubMed: 10790907]
  223. Room R. Intoxication and bad behaviour: understanding cultural differences in the link. Soc Sci Med. 2001; 53:189-98. [PubMed: 11414386]
  224. Rossow I. Alcohol and homicide: cross-cultural comparison of the relationship in 14 European countries. Addiction. 2001; 96:77-92.
  225. Rehm J, Room R, Taylor B. Method for moderation: measuring lifetime risk of alcohol- attributable mortality as a basis for drinking guidelines. Int J Methods Psychiatr Res. 2008; 17:141-51. [PubMed: 18763694]
  226. Taylor B, Rehm J, Room R, Patra J, Bondy S. Determination of lifetime injury mortality risk in Canada in 2002 by drinking amount per occasion and number of occasions. Am J Epidemiol. 2008; 168:1119-25. [PubMed: 18718895]
  227. Haworth, A.; Simpson, R. Issues in unrecorded alcohol beverage production and consumption. New York: Brunner-Routledge; 2004. Moonshine Markets.
  228. ICAP. Review 3. Noncommercial alcohol in three regions. Washington DC: International Center for Alcohol Policies (ICAP); 2008.
  229. Rehm J, Kanteres F, Lachenmeier DW. Unrecorded consumption, quality of alcohol and health consequences. Drug Alcohol Review. Accepted.
  230. Lachenmeier DW, Sarsh B, Rehm J. The composition of alcohol products from markets in Lithuania and Hungary, and potential health consequences: a pilot study. Alcohol Alcohol. 2009; 44:93-102. [PubMed: 19033379]
  231. Kanteres F, Lachenmeier DW, Rehm J. Alcohol in Mayan Guatemala: consumption, distribution, production, and composition of Cuxa. Addiction. 2009; 104:752-259. [PubMed: 19215596]
  232. Lachenmeier DW, Kuballa T, Lima MCP, Nóbrega ICC, Kerr-Corrêa F, Kanteres F, et al. Ethyl carbamate analysis in German fruit spirits and Brazilian sugarcane spirits (cachaça): improved sample cleanup with automated parallel evaporation. Deutsche Lebensmittel-Rundschau. 2009; 105:507-12.
  233. Knupfer G. Drinking for health: the daily light drinker fiction. Br J Addict. 1987; 82:547-55. [PubMed: 3474009]
  234. Dawson DA, Room R. Towards agreement on ways to measure and report drinking patterns and alcohol-related problems in adult general population surveys: Skarpö Conference Overview. J Subst Abuse. 2000; 12:1-21. [PubMed: 11288465]
  235. Greenfield TK, Kerr WC. Alcohol measurement methodology in epidemiology: recent advances and opportunities. Addiction. 2008; 103:1082-99. [PubMed: 18422826]
  236. Rehm J, Sulkowska U, Manczuk M, Boffetta P, Powles J, Popova S, et al. Alcohol accounts for a high proportion of premature mortality in central and eastern Europe. Int J Epidemiol. 2007; 36:458-67. [PubMed: 17251244]
  237. Stockwell T, Single E, Hawks D, Rehm J. Sharpening the focus of alcohol policy from aggregate consumption to harm and risk reduction. Addiction Research. 1997; 5:1-9.
  238. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008; 16:CD007176. [PubMed: 18425980]
  239. Kalichman SC, Simbayi LC, Vermaak R, Cain D, Jooste S, Peltzer K. HIV/AIDS risk reduction counseling for alcohol using sexually transmitted infections clinic patients in Cape Town South Africa. J Acquir Immune Defic Syndr. 2007; 44:594-600. [PubMed: 17325606]
  240. Kalichmann SC, Simbayi LC, Vermaak R, Cain D, Smith G, Mthebu J, et al. Randomized trial of a community-based alcohol-related HIV risk-reduction intervention for men and women in Cape Town South Africa. Ann Behav Med. 2008; 36:270-9. [PubMed: 18836789]
  241. Rehm, J.; Samokhvalov, AV.; Popova, S.; Neuman, MG.; Room, R.; Parry, C., et al. A systematic review and meta-analysis. Toronto, ON: CAMH; 2009. Alcohol consumption, alcohol use disorders and incidence and disease course of tuberculosis (TB) -is there a causal connection?.
  242. Zeka A, Gore R, Kriebel D. Effects of alcohol and tobacco on aerodigestive cancer risks: a meta- regression analysis. Cancer Causes Control. 2003; 14:897-906. [PubMed: 14682447]
  243. Purdue MP, Hashibe M, Berthiller J, La Vecchia C, Dal Maso L, Herrero R, et al. Type of alcoholic beverage and risk of head and neck cancer. A pooled analysis within the INHANCE Consortium Meta-analysis. Am J Epidemiol. 2009; 169:132-42. [PubMed: 19064644]
  244. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res Health. 2001; 25:263-70. [PubMed: 11910703]
  245. Lewis SJ, Smith DG. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev. 2005; 14:1967-71. [PubMed: 16103445]
  246. Shimazu T, Tsuji I, Inoue M, Wakai K, Nagata C, Mizoue T, et al. Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Alcohol drinking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2008; 38:8-25. [PubMed: 18258712]
  247. Mizoue T, Inoue M, Wakai K, Nagata C, Shimazu T, Tsuji I, et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Meta- analysis. Am J Epidemiol. 2008; 167:1397-406. [PubMed: 18420544]
  248. Altieri A, Garavello W, Boseti C, Gallus S, Vecchia CL. Alcohol consumption and risk of laryngeal cancer. Oral Oncology. 2005; 41:956-65. [PubMed: 15927525]
  249. La Vecchia C, Zhang ZF, Altieri A. Alcohol and laryngeal cancer: an update. Eur J Cancer Prev. 2008; 17:116-24. [PubMed: 18287868]
  250. Korte JE, Brennan P, Henley SJ, Boffetta P. Dose-specific metaanalysis and sensitivity analysis of the relation between alcohol consumption and lung cancer risk. Am J Epidemiol. 2002; 155:496-506. [PubMed: 11882523]
  251. Freudenheim JL, Ritz J, Smith-Warner SA, Albanes D, Bandera EV, van den Brandt PA, et al. Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies. Am J Clin Nutr. 2005; 82:657-67. [PubMed: 16155281]
  252. Chao C. Associations between beer, wine, and liquor consumption and lung cancer risk: a meta- analysis. Cancer Epidemiol Biomarkers Prev. 2007; 16:2436-47. [PubMed: 18006934]
  253. Bandera E, Freudenheim J, Vena J. Alcohol and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 2001; 10:813-21. [PubMed: 11489747]
  254. Wakai K, Nagata C, Mizoue T, Nishino Y, Tsuji I, Inoue M, et al. Alcohol drinking and lung cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol. 2007; 37:168-74. [PubMed: 17332056]
  255. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt P, Folsom AR, Goldbohm RA, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998; 279:535- 40. [PubMed: 9480365]
  256. Ellison R, Zhang Y, McLennan C, Rothman K. Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol. 2001; 154:740-7. [PubMed: 11590087]
  257. Suzuki R, Orsini N, Mignone L, Saji S, Wolk A. Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status. A meta-analysis of epidemiological studies. Int J Cancer. 2008; 122:1832-41. [PubMed: 18067133]
  258. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med. 2004; 140:211-9. [PubMed: 14757619]
  259. Carlsson S, Hammar N, Grill V. Alcohol consumption and type 2 diabetes meta-analysis of epidemiological studies indicates a u-shaped relationship. Diabetologia. 2005; 48:1051-4. [PubMed: 15864527]
  260. Koppes LLJ, Bouter LM, Dekker JM, Heine RJ, Hendricks HFJ. Moderate alcohol consumption lowers the risk of type 2 diabetes. A meta-analysis of prospective observational studies. Diabetes Care. 2005; 28:719-25. [PubMed: 15735217]
  261. Ashley M, Rehm J, Bondy S, Single E, Rankin J. Beyond ischemic heart disease: are there other health benefits from drinking alcohol? Contemp Drug Probl. 2000; 27:735-77.
  262. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case- control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991; 20:S48-S57. [PubMed: 1833354]
  263. Letenneur L, Larrieu S, Barberger-Gateau P. Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies. Biomed Pharmacother. 2004; 58:95-9. [PubMed: 14992790]
  264. Letenneur L. Moderate alcohol consumption and risk of developing dementia in the elderly: the contribution of propsective studies. Ann Epidemiol. 2007; 17:S43-S45.
  265. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age and Ageing. 2008; 37:505-12. [PubMed: 18487267]
  266. Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Santamato A, et al. Vascular risk factors, alcohol intake, and cognitive decline. J Nutr Health Aging. 2008; 12:376-81. [PubMed: 18548174]
  267. Tyas SL. Alcohol use and the risk of developing Alzheimer's disease. Alcohol Res Health. 2001; 25:299-306. [PubMed: 11910708]
  268. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation. 2002; 105:2836-44. [PubMed: 12070110]
  269. Camargo CA. Moderate alcohol consumption and stroke: the epidemiologic evidence. Stroke. 1989; 20:1611-26. [PubMed: 2688194]
  270. Mazzaglia G, Britton R, Altmann DR, Chenet L. Exploring the relationship between alcohol consumption and non-fatal or fatal stroke: a systematic review. Addiction. 2001; 96:1743-56. [PubMed: 11784467]
  271. Teunissen LL, Rinkel GJE, Algra A, van Gijn J. Risk factors for subarachnoid hemorrhage: a systematic review. Stroke. 1996; 27:544-9. [PubMed: 8610327]
  272. Henderson J, Gray R, Brocklehurst P. Systematic review of effects of low-moderate prenatal alcohol exposure on pregnancy outcome. BJOG. 2007; 114:243-52. [PubMed: 17233797]
  273. Henderson J, Kesmodel U, Gray R. Systematic review of the fetal effects of prenatal binge- drinking. J Epidemiol Community Health. 2007; 61:1069-73. [PubMed: 18000129]
  274. Odendaal HJ, Steyn DW, Elliott A, Burd L. Combined effects of cigarette smoking and alcohol consumption on perinatal outcome. Gynecol Obstet Invest. 2009; 67:1-8. [PubMed: 18685256]
  275. Abel EL, Hannigan JH. 'J-shaped' relationship between drinking during pregnancy and birth weight: reanalysis of prospective epidemiological data. Alcohol Alcohol. 1995; 30:345-55. [PubMed: 7545989]
  276. Zuckerman BS, Hingson R. Alcohol consumption during pregnancy: a critical review. Developmental Medicine and Child Neurology. 1986; 28:649-54. [PubMed: 3536641]
  277. Baliunas D, Taylor B, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a risk factor for type 2 diabetes -a systematic review and meta-analysis. Diabetes Care. 2009; 32:2123-32. [PubMed: 19875607]
  278. Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009 Epub ahead of print October 5.
  279. Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Public Health. Submitted.
  280. Klatsky AL, Friedman GD, Armstrong MA, Kipp H. Wine, liquor, beer, and mortality. Am J Epidemiol. 2003; 158:585-95. [PubMed: 12965884]